Toby Michael Maher
Toby Michael Maher
Royal Brompton Hospital
Email verificata su rbht.nhs.uk
TitoloCitata daAnno
Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis
L Richeldi, RM Du Bois, G Raghu, A Azuma, KK Brown, U Costabel, ...
New England Journal of Medicine 370 (22), 2071-2082, 2014
20172014
Interstitial lung disease in systemic sclerosis: a simple staging system
NSL Goh, SR Desai, S Veeraraghavan, DM Hansell, SJ Copley, ...
American journal of respiratory and critical care medicine 177 (11), 1248-1254, 2008
7012008
Idiopathic pulmonary fibrosis: a composite physiologic index derived from disease extent observed by computed tomography
AU Wells, SR Desai, MB Rubens, NSL Goh, D Cramer, AG Nicholson, ...
American journal of respiratory and critical care medicine 167 (7), 962-969, 2003
5332003
Genome-wide association study identifies multiple susceptibility loci for pulmonary fibrosis
TE Fingerlin, E Murphy, W Zhang, AL Peljto, KK Brown, MP Steele, ...
Nature genetics 45 (6), 613, 2013
4222013
Acute exacerbation of idiopathic pulmonary fibrosis. An international working group report
HR Collard, CJ Ryerson, TJ Corte, G Jenkins, Y Kondoh, DJ Lederer, ...
American journal of respiratory and critical care medicine 194 (3), 265-275, 2016
3762016
Idiopathic pulmonary fibrosis: multiple causes and multiple mechanisms?
TM Maher, AU Wells, GJ Laurent
European Respiratory Journal 30 (5), 835-839, 2007
3002007
Increased local expression of coagulation factor X contributes to the fibrotic response in human and murine lung injury
CJ Scotton, MA Krupiczojc, M Königshoff, PF Mercer, YCG Lee, ...
The Journal of clinical investigation 119 (9), 2550-2563, 2009
2742009
The role of bacteria in the pathogenesis and progression of idiopathic pulmonary fibrosis
PL Molyneaux, MJ Cox, SAG Willis-Owen, P Mallia, KE Russell, ...
American journal of respiratory and critical care medicine 190 (8), 906-913, 2014
2482014
Pleuroparenchymal fibroelastosis: a spectrum of histopathological and imaging phenotypes
TL Reddy, M Tominaga, DM Hansell, J von der Thusen, D Rassl, ...
European Respiratory Journal 40 (2), 377-385, 2012
2052012
Lysophosphatidic acid induces αvβ6 integrin-mediated TGF-β activation via the LPA2 receptor and the small G protein Gαq
MY Xu, J Porte, AJ Knox, PH Weinreb, TM Maher, SM Violette, ...
The American journal of pathology 174 (4), 1264-1279, 2009
1752009
Significance of connective tissue disease features in idiopathic interstitial pneumonia
TJ Corte, SJ Copley, SR Desai, CJ Zappala, DM Hansell, AG Nicholson, ...
European Respiratory Journal 39 (3), 661-668, 2012
1652012
Longitudinal change in collagen degradation biomarkers in idiopathic pulmonary fibrosis: an analysis from the prospective, multicentre PROFILE study
RG Jenkins, JK Simpson, G Saini, JH Bentley, AM Russell, R Braybrooke, ...
The lancet Respiratory medicine 3 (6), 462-472, 2015
1612015
Diminished prostaglandin E2 contributes to the apoptosis paradox in idiopathic pulmonary fibrosis
TM Maher, IC Evans, SE Bottoms, PF Mercer, AJ Thorley, AG Nicholson, ...
American journal of respiratory and critical care medicine 182 (1), 73-82, 2010
1602010
Rituximab in severe, treatment‐refractory interstitial lung disease
GJ Keir, TM Maher, D Ming, R Abdullah, A de Lauretis, ...
Respirology 19 (3), 353-359, 2014
1462014
Mucin 5B promoter polymorphism is associated with idiopathic pulmonary fibrosis but not with development of lung fibrosis in systemic sclerosis or sarcoidosis
CJ Stock, H Sato, C Fonseca, WAS Banya, PL Molyneaux, H Adamali, ...
Thorax 68 (5), 436-441, 2013
1402013
Serum interleukin 6 is predictive of early functional decline and mortality in interstitial lung disease associated with systemic sclerosis
A De Lauretis, P Sestini, P Pantelidis, R Hoyles, DM Hansell, NSL Goh, ...
The Journal of rheumatology 40 (4), 435-446, 2013
1262013
Antacid therapy and disease outcomes in idiopathic pulmonary fibrosis: a pooled analysis
M Kreuter, W Wuyts, E Renzoni, D Koschel, TM Maher, M Kolb, ...
The Lancet Respiratory Medicine 4 (5), 381-389, 2016
1232016
Combination therapy: the future of management for idiopathic pulmonary fibrosis?
WA Wuyts, KM Antoniou, K Borensztajn, U Costabel, V Cottin, B Crestani, ...
The lancet Respiratory medicine 2 (11), 933-942, 2014
1102014
Bosentan in pulmonary hypertension associated with fibrotic idiopathic interstitial pneumonia
TJ Corte, GJ Keir, K Dimopoulos, L Howard, PA Corris, L Parfitt, C Foley, ...
American journal of respiratory and critical care medicine 190 (2), 208-217, 2014
1082014
Nintedanib in patients with idiopathic pulmonary fibrosis and preserved lung volume
M Kolb, L Richeldi, J Behr, TM Maher, W Tang, S Stowasser, C Hallmann, ...
Thorax 72 (4), 340-346, 2017
1062017
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20